Jiangsu Hengrui Medicine Statistics

Total Valuation

Jiangsu Hengrui Medicine has a market cap or net worth of CNY 286.20 billion. The enterprise value is 263.94 billion.

Market Cap	286.20B
Enterprise Value	263.94B

Important Dates

The next estimated earnings date is Monday, March 31, 2025.

Earnings Date	Mar 31, 2025
Ex-Dividend Date	Jul 12, 2024

Share Statistics

Jiangsu Hengrui Medicine has 6.36 billion shares outstanding. The number of shares has decreased by -0.70% in one year.

Current Share Class	n/a
Shares Outstanding	6.36B
Shares Change (YoY)	-0.70%
Shares Change (QoQ)	+1.34%
Owned by Insiders (%)	0.15%
Owned by Institutions (%)	20.92%
Float	3.40B

Valuation Ratios

The trailing PE ratio is 52.35 and the forward PE ratio is 48.39. Jiangsu Hengrui Medicine's PEG ratio is 13.33.

PE Ratio	52.35
Forward PE	48.39
PS Ratio	10.97
PB Ratio	6.45
P/TBV Ratio	6.72
P/FCF Ratio	45.56
P/OCF Ratio	n/a
PEG Ratio	13.33

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 42.32, with an EV/FCF ratio of 42.01.

EV / Earnings	48.45
EV / Sales	10.15
EV / EBITDA	42.32
EV / EBIT	48.35
EV / FCF	42.01

Financial Position

The company has a current ratio of 9.00, with a Debt / Equity ratio of 0.00.

Current Ratio	9.00
Quick Ratio	7.79
Debt / Equity	0.00
Debt / EBITDA	0.01
Debt / FCF	0.01
Interest Coverage	1,220.04

Financial Efficiency

Return on equity (ROE) is 12.88% and return on invested capital (ROIC) is 8.05%.

Return on Equity (ROE)	12.88%
Return on Assets (ROA)	7.48%
Return on Capital (ROIC)	8.05%
Revenue Per Employee	1.33M
Profits Per Employee	277,815
Employee Count	19,611
Asset Turnover	0.57
Inventory Turnover	1.49

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -0.25% in the last 52 weeks. The beta is 0.29, so Jiangsu Hengrui Medicine's price volatility has been lower than the market average.

Beta (5Y)	0.29
52-Week Price Change	-0.25%
50-Day Moving Average	47.96
200-Day Moving Average	45.04
Relative Strength Index (RSI)	29.99
Average Volume (20 Days)	35,920,370

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Jiangsu Hengrui Medicine had revenue of CNY 26.00 billion and earned 5.45 billion in profits. Earnings per share was 0.86.

Revenue	26.00B
Gross Profit	22.26B
Operating Income	5.46B
Pretax Income	5.94B
Net Income	5.45B
EBITDA	6.20B
EBIT	5.46B
Earnings Per Share (EPS)	0.86

Full Income Statement

Balance Sheet

The company has 22.91 billion in cash and 87.58 million in debt, giving a net cash position of 22.82 billion or 3.59 per share.

Cash & Cash Equivalents	22.91B
Total Debt	87.58M
Net Cash	22.82B
Net Cash Per Share	3.59
Equity (Book Value)	44.33B
Book Value Per Share	6.98
Working Capital	30.63B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.92 billion and capital expenditures -1.64 billion, giving a free cash flow of 6.28 billion.

Operating Cash Flow	7.92B
Capital Expenditures	-1.64B
Free Cash Flow	6.28B
FCF Per Share	0.99

Full Cash Flow Statement

Margins

Gross margin is 85.62%, with operating and profit margins of 21.00% and 20.96%.

Gross Margin	85.62%
Operating Margin	21.00%
Pretax Margin	22.86%
Profit Margin	20.96%
EBITDA Margin	23.85%
EBIT Margin	21.00%
FCF Margin	24.17%

Dividends & Yields

This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.45%.

Dividend Per Share	0.20
Dividend Yield	0.45%
Dividend Growth (YoY)	25.00%
Years of Dividend Growth	1
Payout Ratio	23.40%
Buyback Yield	0.70%
Shareholder Yield	1.15%
Earnings Yield	1.91%
FCF Yield	2.20%

Dividend Details

Stock Splits

The last stock split was on Invalid Date. It was a forward split with a ratio of 1.2.

Last Split Date	Invalid Date
Split Type	Forward
Split Ratio	1.2

Scores

Jiangsu Hengrui Medicine has an Altman Z-Score of 44.27.

Altman Z-Score	44.27
Piotroski F-Score	n/a